Status:
COMPLETED
Compliance of Long-term Home Non-invasive Ventilation for Patients With Chronic Obstructive Pulmonary Disease
Lead Sponsor:
Vivisol
Collaborating Sponsors:
Slb Pharma
France Oxygène
Conditions:
Chronic Obstructive Pulmonary Disease
Eligibility:
All Genders
18+ years
Brief Summary
Background : Long-term home non-invasive ventilation (NIV) can be proposed as treatment for acute respiratory failure with severe alveolar hypoventilation. The aim of NIV is to correct both daytime an...
Eligibility Criteria
Inclusion
- COPD patients who require the initiation of a home-NIV (in case of previous equipment: NIV interrupted for more than 6 months).
- Life expectancy greater than 1 year.
- Patient who has agreed to participate in the observational study after receiving clear information from the investigator and signing the consent form.
Exclusion
- NIV indicated for the treatment of chronic respiratory failure other than COPD.
- Patient with overlap syndrome (COPD associated to OSA).
- Patient with limitations who do not allow proper use of the NIV device.
- Simultaneous participation in a health intervention research.
Key Trial Info
Start Date :
December 16 2019
Trial Type :
OBSERVATIONAL
Allocation :
ACTUAL
End Date :
December 31 2022
Estimated Enrollment :
25 Patients enrolled
Trial Details
Trial ID
NCT04333901
Start Date
December 16 2019
End Date
December 31 2022
Last Update
March 15 2023
Active Locations (8)
Enter a location and click search to find clinical trials sorted by distance.
1
Pays d'Aix hospital
Aix-en-Provence, France, 13616
2
Cannes hospital
Cannes, France, 06414
3
Henri-Mondor hospital (APHP)
Créteil, France, 94010
4
Institut Médical de Sologne Les Pins
Lamotte-Beuvron, France, 41600